Compass Pathways appears to have completed an impulsive 5-wave move to the upside, signaling significant strength in its recent price action. The peak of this move, reaching $12.75, is notably identified as the B wave within an extended flat correction, potentially forming part of a larger 5-wave pattern.
In anticipation of a corrective phase, I anticipate a...
The stock has positive momentum, breaking out a long shuffle
Caution is required... According to the SEC, there have recently been sales by insiders.
Oscillators in positive territory
$12.3 critical level (Note that the volume supports the resistance breakout)
You will find target price (first) in the attached picture
Full disclosure I am in a position from about...
After breaking the major S/R zone and retesting it successfully I'm seeing clear upside potential from a technical viewpoint. Areas plotted to look out for, combined with trend lines, daily and weekly moving averages.
The next hype narrative after crypto has its bull run and seems “tapped out” will be psychedelics having a clinical use case and the runway for approval lines up perfectly. Compass has established itself as the best positioned player in the game and the shares have never been more reasonable. I am a continued buyer on anything 6 or below just because this is a...
5 minutes ago
Breakout Divergence Formation. Bottom Forming Around $6/share.
Context:
Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalization. Psilocybin is another psychoactive substance classified...
Breakout Divergence Formation. Bottom Forming Around $6/share.
Context:
Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalization. Psilocybin is another psychoactive substance classified similarly to...
CMPS is forming a nice bull pennant.
First PT 24. Wait for break above white line (21 DMA ) for confirmation as an idea.
Break below 14 invalidates trade.
psychedelic is the future for mental health. I don't understand why the chart doesn't move but it will be because nothing else can heal the mental illness. At this moment we only have 20 years of Internet. We need to go forward. Psychotherapy doesn't work because sometimes even the client doesn't know what he have. I don't say that compass pathway will be the...
Okay okay, I was way too early on this one and called it right when a bunch of Macro factors took a shit on the market. So yeah. Anyways now is the time.
Thought I'd make this post since I am sampling their "product" and to correct my prior early calls. Their product is amazing and is a godsend for those that suffer from anxiety, depression, etc.
All targets...
Magic Mushrooms. CMPS and their shrooms have been on a downward consolidation for what has felt like a year now. No edge on the weekly as price moves to test support. I, like so many others, are looking for signs of accumulation and seller exhaustion before the next step can occur.
Looks like the MACD is still heading down but curling up. RSI is bottoming out as it reaches an important level of support. I think the risk reward at the $28 level is optimal. If you have a high risk tolerance, buy now.
Shrooms are already decriminalized in Denver and are about to be in Detroit.
The TAM which was initially an imaginative number is now becoming...
Swing Long $CMPS low 34s, will add. Looking for +$4 at least. This name may bounce today (11/10/2021) for +$1 to +$2 but I'm holding for +$4.
$CMPS target will be 37 to 39, Im gonna drop the first piece of $CMPS for +$2.
Credit: Dan Parker (Pro trader in TrueTrader Pro Chatroom)
Compass Pathways deals with psychedelics and their promising properties when it comes to the treatment of mental illnesses.
Purple Zone: Safe Entry
Green Zone: Risk Entry
76% potential return.
Citron Research has a $100 PT.
Citigroup has a $67 PT.
Bullish MACD cross
Consolidating for the past 113 days
Compass pathways is showing a falling wedge after a bullish harmonic on the weekly. (My harmonic skills are new, so it could be bogus, but the wedge is legit.) There is rsi bullish divergence as well as 3x class A macd bullish divergrnce. Just in terms of playing it safe, the tske profit is at the 1.618 of the wedge around 50 bucks. If that harmonic wants to run,...
CMPS - Long above $33.77 for shares or options. Personally I would take the December 34/35C on break above.
PT1: $38-$40 (trim 50-75% of your position here) - If playing 1 option, I would cut position here and take profits.
PT2: $43.50 - $47.40
SL: On break above, my SL would be $33.20
Wait it out. The future is bright & no need to rush. FOMO investing is a disaster. Small caps with revenue growth & profits NOW matter most.
*rising rate environment
$GNLN #thegem #cannabisreform
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS...
